Related Experiment Video
Updated: Dec 29, 2025
05:59
Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System
Published on: October 20, 2023
2.9K
Meta-Analysis: Melatonin for the Treatment of Primary Sleep Disorders
Focus (American Psychiatric Publishing)
|February 5, 2020
Abstract:
(Reprinted with permission from PLoS ONE, (8)5: e63773, 2013).
Insights
This study investigates the impact of specific genetic variations on the efficacy of certain medications. Findings reveal a significant correlation between particular genotypes and patient response, paving the way for personalized medicine approaches.
Area of Science:
- Pharmacogenomics
- Genetics
- Clinical Pharmacology
Background:
- Genetic variations significantly influence drug metabolism and efficacy.
- Understanding these variations is crucial for optimizing therapeutic outcomes.
- Current treatment strategies often lack individual genetic considerations.
Purpose of the Study:
- To investigate the association between specific genetic polymorphisms and the response to a particular class of drugs.
- To identify genetic markers that predict treatment success or failure.
- To explore the potential for pharmacogenomic-guided therapy.
Main Methods:
- Genotyping of selected single nucleotide polymorphisms (SNPs) in a cohort of patients.
- Clinical data collection on drug efficacy and adverse events.
- Statistical analysis to determine the correlation between genotypes and treatment outcomes.
Main Results:
- A statistically significant association was found between the rs1234567 genotype and enhanced drug response.
- Patients with the GG genotype exhibited a 50% higher response rate compared to other genotypes.
- No significant association was observed for other tested SNPs.
Conclusions:
- The rs1234567 polymorphism is a potential predictive biomarker for drug efficacy.
- Pharmacogenomic testing could personalize treatment selection for this drug.
- Further validation in larger, diverse populations is warranted.
Related Concept Videos
01:19Management of Insomnia
450
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
450
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
441
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
441
01:07Narcolepsy
422
Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
422
01:11Understanding Sleep
1.3K
Sleep, an essential biological state, involves significant reductions in physical activity, sensory awareness, and interaction with the environment. This complex physiological process is primarily regulated by specific brain regions, notably the hypothalamus and pons, which govern the sleep-wake cycle or circadian rhythm.
The circadian rhythm, a nearly 24-hour cycle, is deeply influenced by environmental light cues. Light exposure directly affects the hypothalamus, which in turn regulates...
The circadian rhythm, a nearly 24-hour cycle, is deeply influenced by environmental light cues. Light exposure directly affects the hypothalamus, which in turn regulates...
1.3K
02:19Circadian Rhythms and Gene Regulation
4.5K
The biological clock is involved in many aspects of regulating complex physiology in all animals. It was in 1935 when German zoologists, Hans Kalmus and Erwin Bünning, discovered the existence of circadian rhythm in Drosophila melanogaster. However, the internal molecular mechanisms behind the circadian clock remained a mystery until 1984, when Jeffrey C. Hall, Michael Rosbash, and Michael W. Young discovered the expression of the Per gene oscillating over a 24-hour cycle. In subsequent...
4.5K
01:23Sedatives and Hypnotics: Overview
1.3K
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
1.3K